

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
You can purchase shares of MediWound (NASDAQ:MDWD) through any online brokerage.
Other companies in MediWound’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
MediWound has a consensus price target of $34.25.
The stock price for MediWound (NASDAQ: MDWD) is $12.065 last updated October 26, 2026 at 4:00 PM EDT.
There are no upcoming dividends for MediWound.
MediWound does not have any upcoming earnings scheduled.
There is no upcoming split for MediWound.
MediWound is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds,...